No Picture
News

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody

– Study demonstrated 100% efficacy in prevention of parvovirus infection in prophylactic pivotal study of KIND-030

SAN FRANCISCO, Sept. 16, 2020 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving an… […]

No Picture
News

Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuvanted COVID-19 Vaccine

– Dynavax will provide CpG 1018 to produce up to 190 million doses over a five year period to support Valneva’s contract with the U.K. government- Inactivated, adjuvanted SARS-COV-2 vaccine candidate scheduled to enter first clinical studies in Decembe… […]

No Picture
News

Varian Announces Goshen Center for Cancer Care Treats First Patient with Ethos® Therapy, Expanding Access to Personalized Cancer Care

Adaptive therapy provides the ability to personalize patient treatment at the time of treatment based on patient’s anatomy and precise position– Ethos therapy combines multi-modality images with an artificial intelligence (AI)-driven Adaptive Intellig… […]

No Picture
News

Sutro Biopharma Presents Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer at the 2020 IGCS Annual Global Meeting

– Updated Data Further Demonstrate Promising Efficacy and Safety Profile in a Heavily Pretreated Patient Population Not Selected Based on Receptor Expression- Conference Call Today Scheduled for 5:30 p.m. Eastern Time

SOUTH SAN FRANCISCO, Calif., Sep… […]

No Picture
News

BioMarin Announces The Lancet Publishes Detailed Vosoritide Phase 3 Data Demonstrating Statistically Significant Increase in Annualized Growth Velocity (AGV) Over 52 Weeks in Children with Achondroplasia

Statistically Significant Increases in Height Z ScorePrespecified Subgroup Analysis Demonstrates Consistent AGV and Z Score increases Over Placebo

SAN RAFAEL, Calif., Sept. 8, 2020 /PRNewswire/ — BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today ann… […]

No Picture
News

Gala Therapeutics Announces Publication of Multicenter Study of the Minimally Invasive RheOx(TM) System in Patients with Chronic Bronchitis

MENLO PARK, Calif., Sept. 3, 2020 /PRNewswire/ — Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, today announced the publication of the results from its initial study evaluating the RheOx™ Bronchial Rheopl… […]

No Picture
News

Multi-site study to evaluate the role of testing guidelines in ensuring access to genetic information for men with prostate cancer

— 1 in 9 men will be diagnosed with prostate cancer in their lifetime —- Prostate cancer awareness month calls attention to need for research and testing —

SAN FRANCISCO, Sept. 3, 2020 /PRNewswire/ — Invitae (NYSE: NVTA), a leading me… […]

No Picture
News

Eiger Announces Peginterferon Lambda – Lonafarnib Combination End of Treatment Results from Phase 2 LIFT HDV Study in Late Breaker Session at The Digital International Liver Congress(TM) 2020

– 96% of Patients Achieve Primary Endpoint of > 2 Log Decline in HDV RNA- 58% of Patients Below Limit of Quantitation or Undetectable at Week 24

PALO ALTO, Calif., Aug. 31, 2020 /PRNewswire/ — Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), focused o… […]

No Picture
News

Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference

SAN FRANCISCO and SUZHOU, China, Aug. 30, 2020 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent” or “the Company”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for th… […]